Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHay fever is not a known side effect of Mounjaro, and Mounjaro does not treat hay fever. That needs saying plainly, because online forums have generated considerable confusion on both points. Tirzepatide works on GIP and GLP-1 receptors involved in appetite and blood-glucose regulation — not on the histamine pathways that drive seasonal allergic rhinitis. What some people on Mounjaro do notice is a temporary fever-like feeling, particularly around dose increases, and that is an entirely different phenomenon. If you are currently taking Mounjaro and experiencing hay fever alongside it, the practical questions are about interactions and timing, not about the medicine causing or curing your seasonal symptoms. These are prescription-only medicines; a GPhC-registered prescriber makes the clinical judgements, not the internet.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A thread on a weight-loss forum can snowball quickly. Several people noticed their eyes were itching and their nose was running after starting Mounjaro in spring, connected the two events, and a myth took hold. The timing was coincidental, spring is hay fever season across the UK, and millions of people experience it whether they are on any medicine or not.
Tirzepatide's side-effect profile is well-documented across large clinical trials. The consistently reported effects are gastrointestinal: nausea, loose stools, constipation, and reflux are the ones that appear most often, particularly in the first weeks. Headache and fatigue also feature. Allergic rhinitis (runny nose, sneezing, itchy eyes driven by an IgE response to pollen) does not. The NHS Mounjaro medicines page lists the known side effects clearly, and hay fever is not among them.
That said, tirzepatide can cause a low-grade flu-like feeling in some people, especially around a dose step-up. This is different from an allergic reaction. If you are unsure whether what you are experiencing is a Mounjaro side effect, seasonal allergy or something else, the right call is to contact your prescriber. Our guide on Mounjaro and fever symptoms covers that distinction in detail, and if you want to understand more about raised temperature specifically, our page on tirzepatide and fever goes into that experience in more depth.
Most people managing hay fever in the UK reach for a daily antihistamine, cetirizine, loratadine or fexofenadine are the common choices. None of these are known to interact adversely with tirzepatide. The BNF (the prescriber reference used across UK clinical practice) does not flag a clinically significant interaction between tirzepatide and standard oral antihistamines.
One nuance worth understanding: Mounjaro slows gastric emptying, which is part of how it reduces appetite. This can affect the rate at which other oral medicines are absorbed. For antihistamines taken as a one-off or daily, this is unlikely to cause a problem in practice, their effects are not narrowly time-dependent in the way that some other medicines are. The more clinically relevant absorption concern applies to oral contraceptives, where specific guidance exists; that is a separate topic covered in the tirzepatide overview.
Nasal corticosteroid sprays (such as beclomethasone or fluticasone) are often more effective for moderate hay fever than antihistamines alone, and these work locally in the nasal passages, the gastric emptying question does not apply. If you use eye drops, nasal sprays or other non-oral routes for hay fever, there is no known interaction with Mounjaro.
Still, if you are starting Mounjaro while already using hay fever treatments, or adding a new hay fever medicine during your treatment, mentioning it to your prescriber at your next review is sensible. It costs nothing to flag it and rules out any edge-case concern. You can always reach us through our support team, available seven days a week.
Hay fever season in the UK broadly runs from March to September, with tree pollen peaking earlier and grass pollen later. For many people, this overlaps with the period when they are either starting Mounjaro or reaching their maintenance dose. Two things are worth keeping in mind.
First, if your hay fever symptoms are severe and you are also experiencing the GI side effects that often accompany a dose increase, managing both at once can be uncomfortable. Neither condition makes the other worse in any direct clinical sense, but feeling rough on two fronts at the same time is worth acknowledging. Staying hydrated matters for both: GI symptoms from tirzepatide and the fatigue that accompanies allergic inflammation both worsen with dehydration. The NHS obesity treatment guidance emphasises lifestyle support alongside weight-loss medicine, and this kind of practical management sits within that frame.
Second, some people on Mounjaro ask whether they should pause treatment during a difficult pollen season. The answer, in short, is that this is a prescriber decision rather than a self-management one. Stopping and restarting GLP-1 medicines is not straightforward, and our page on whether you can stay on Mounjaro long term covers the evidence around duration of treatment in detail, with more on whether taking Mounjaro indefinitely is a realistic option for people considering that question.
If cost is a factor in your thinking about managing multiple treatments, our Mounjaro cost in the UK guide explains what legitimate private treatment typically includes, and why the headline price is rarely the full picture.
Most hay fever alongside Mounjaro is a seasonal inconvenience, not a medical emergency. There are exceptions. Seek urgent help if you experience signs of a serious allergic reaction, swelling of the face, lips or throat, difficulty breathing, or a widespread rash developing rapidly. These are symptoms of anaphylaxis, not hay fever, and they require emergency care immediately.
Contact your prescriber if your hay fever symptoms are unusually severe and you cannot tell whether they are allergy-related or connected to your Mounjaro treatment. Also get in touch if you want to add a new prescription medicine for hay fever rather than an over-the-counter antihistamine, some prescription antihistamines and nasal treatments need a clinical conversation in context.
You can report any suspected side effect from tirzepatide, including symptoms that seem unexpected, through the MHRA Yellow Card scheme. It is open to patients as well as clinicians, and genuine reports contribute to the evidence base for medicines that are still under active monitoring.
If you have questions about starting Mounjaro or reviewing your current treatment, a prescriber at our consultation service can review your situation the same day, with aftercare available across the week.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.